MM-589
CAS No. 2097887-21-1
MM-589 ( MM 589;MM589 )
Catalog No. M13312 CAS No. 2097887-21-1
A highly potent, cell-permeable inhibitor of WDR5-MLL interaction with IC50 of 0.9 nM, Ki of <1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 1773 | Get Quote |
|
50MG | 3582 | Get Quote |
|
100MG | 4950 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMM-589
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent, cell-permeable inhibitor of WDR5-MLL interaction with IC50 of 0.9 nM, Ki of <1 nM.
-
DescriptionA highly potent, cell-permeable inhibitor of WDR5-MLL interaction with IC50 of 0.9 nM, Ki of <1 nM; inhibits the MLL H3K4 methyltransferase activity (IC50=12.7 nM), potently and selectively inhibits cell growth in human leukemia cell lines harboring MLL translocations, and shows >40-fold better than MM-401.
-
SynonymsMM 589;MM589
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2097887-21-1
-
Formula Weight686.73
-
Molecular FormulaC30H45F3N8O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCC1C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)N1)CCCNC(=NC)N)(C)NC(=O)C(C)C)C2=CC=CC=C2.C(=O)(C(F)(F)F)O
-
Chemical NameN-((3R,6S,9S,12R)-6-ethyl-12-methyl-9-(3-(3-methylguanidino)propyl)-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl)isobutyramide 2,2,2-trifluoroacetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Karatas H, et al. J Med Chem. 2017 Jun 22;60(12):4818-4839.
molnova catalog
related products
-
WDR5 WIN site inhibi...
WDR5 WIN site inhibitor C3 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 1.3 nM.
-
MI-538
MI-538 is potent and selective menin–MLL interaction inhibitor (IC50=21 nM).
-
MAK683
MAK683 (MAK-683) is a novel inhibitor of embryonic ectoderm development protein (EED) and allosteric inhibitor of polycomb repressive complex 2 (PRC2).